Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Orthocell.
RELATED STOCKHEAD STORIES
Health & Biotech
Australia’s medical manufacturing sector – a global success story in the making
Health & Biotech
Beyond Resources Part 2: ASX companies driving WA’s medical and life sciences sector
Health & Biotech
Beyond resources: WA aims to be medical and life sciences powerhouse
Health & Biotech
National biotech summit shows off a wealth of healthcare and medical innovation
Health & Biotech
Orthocell to sell Striate+ in Canada after regulatory approval
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Investors are all ears as Orthocell’s nerve and tissue solutions deliver record revenue
News
Closing Bell: ASX buried under -1.3pc as iron ore miners and goldies take a beating
Health & Biotech
ASX Health Stocks: Orthocell seeks TGA approval; Race Oncology gets FDA nod
Health & Biotech
ASX Health Stocks: RAC says combining lead drug bisantrene with decitabine is effective on solid tumours
Health & Biotech
ASX Health Stocks: Argenica flies over 15pc after FDA grants Rare Pediatric Disease Designation
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Forget surgery, Orthocell says tennis elbow can be fixed with its tendon cell therapy
Health & Biotech
ASX Health Stocks: Neuren’s breakthrough Rett Syndrome drug DAYBUE is now officially available in the US
Health & Biotech
ASX Health Stocks: Woolworths’ subsidiary partners with Telehealth stock Global Health, share price up 5pc
Health & Biotech
ASX Biotech Stocks: Surgeons can now be reimbursed for using Orthocell’s nerve repair device
Health & Biotech
